| Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial Y Panahi, N Khalili, E Sahebi, S Namazi, MS Karimian, M Majeed, ... Inflammopharmacology 25, 25-31, 2017 | 225 | 2017 |
| Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial Y Panahi, N Khalili, E Sahebi, S Namazi, LE Simental-Mendía, M Majeed, ... Drug research 68 (07), 403-409, 2018 | 221 | 2018 |
| A comparison of five common drug–drug interaction software programs regarding accuracy and comprehensiveness R Kheshti, M Aalipour, S Namazi Journal of research in pharmacy practice 5 (4), 257-263, 2016 | 213 | 2016 |
| Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial Y Panahi, N Khalili, E Sahebi, S Namazi, Ž Reiner, M Majeed, A Sahebkar Complementary therapies in medicine 33, 1-5, 2017 | 211 | 2017 |
| Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran N Azarpira, S Namazi, F Hendijani, M Banan, M Darai Pharmacological reports 62 (4), 740-746, 2010 | 80 | 2010 |
| Evaluation of prophylactic antibiotic administration at the surgical ward of a major referral hospital, Islamic Republic of Iran G Vessal, S Namazi, MA Davarpanah, F Foroughinia EMHJ-Eastern Mediterranean Health Journal, 17 (8), 663-668, 2011, 2011 | 78 | 2011 |
| Curcuminoids plus piperine modulate adipokines in type 2 diabetes mellitus Y Panahi, N Khalili, E Sahebi, S Namazi, SL Atkin, M Majeed, A Sahebkar Current clinical pharmacology 12 (4), 253-258, 2017 | 74 | 2017 |
| Adherence to American Society of Health-System Pharmacists surgical antibiotic prophylaxis guidelines in Iran M Askarian, AR Moraweji, H Mirkhani, S Namazi, H Weed Infection Control & Hospital Epidemiology 27 (8), 876-878, 2006 | 72 | 2006 |
| Long-term complications of sulphur mustard poisoning in intoxicated Iranian veterans S Namazi, H Niknahad, H Razmkhah Journal of medical toxicology 5, 191-195, 2009 | 66 | 2009 |
| The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran S Namazi, N Azarpira, F Hendijani, MB Khorshid, G Vessal, ... Clinical therapeutics 32 (6), 1050-1060, 2010 | 63 | 2010 |
| Health care workers’ knowledge, attitude, and practice about chronic pain management, Shiraz, Iran R Kheshti, S Namazi, M Mehrabi, D Firouzabadi Anesthesiology and pain medicine 6 (4), 2016 | 51 | 2016 |
| The impact of genetic polymorphisms of P2Y12, CYP3A5 and CYP2C19 on clopidogrel response variability in Iranian patients S Namazi, J Kojuri, A Khalili, N Azarpira Biochemical pharmacology 83 (7), 903-908, 2012 | 50 | 2012 |
| Association of angiotensin I converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms with breast cancer prognostic factors in Iranian … S Namazi, A Monabati, S Ardeshir‐Rouhani‐Fard, N Azarpira Molecular Carcinogenesis 49 (12), 1022-1030, 2010 | 41 | 2010 |
| Incidence of potential drug-drug interaction and related factors in hospitalized neurological patients in two Iranian teaching hospitals S Namazi, S Pourhatami, A Borhani-Haghighi, S Roosta Iranian Journal of Medical Sciences 39 (6), 515, 2014 | 37 | 2014 |
| Serum cystatin C as a marker of renal function in critically ill patients with normal serum creatinine MM Sagheb, S Namazi, B Geramizadeh, A Karimzadeh, MB Oghazian, ... Nephro-urology monthly 6 (2), 2014 | 31 | 2014 |
| Adverse drug reactions reporting: Pharmacists' knowledge, attitude and practice in Shiraz, Iran S Afifi, N Maharloui, P Peymani, S Namazi, AG Gharaei, P Jahani, ... International Journal of Risk & Safety in Medicine 26 (3), 139-145, 2014 | 29 | 2014 |
| Adverse reactions to antiepileptic drugs in epileptic outpatients: a cross-sectional study in Iran S Namazi, A Borhani-Haghighi, I Karimzadeh Clinical neuropharmacology 34 (2), 79-83, 2011 | 27 | 2011 |
| The effect of renin angiotensin system on tamoxifen resistance S Namazi, S Ardeshir-Rouhani-Fard, H Abedtash Medical Hypotheses 77 (1), 152-155, 2011 | 21 | 2011 |
| Vancomycin use in a large teaching hospital in Shiraz, Islamic Republic of Iran, 2003 M Askarian, O Assadian, GR Safaee, A Golkar, S Namazi, MR Movahed EMHJ-Eastern Mediterranean Health Journal, 13 (5), 1195-1201, 2007, 2007 | 20 | 2007 |
| Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report) P Peymani, R Tabrizi, S Afifi, S Namazi, ST Heydari, MK Shirazi, ... International Journal of Risk & Safety in Medicine 28 (1), 25-31, 2016 | 19 | 2016 |
